
Syros Pharmaceuticals, Inc.
USD0.00
+0.00 (+19900.00%)
CEO
James E. Bradner
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.04
Market Cap
$0.00B
Volume
0.00M
| 13 Nov 2024 |
| Brookline Capital |
| Buy |
| Hold |
| downgrade |
| 1 Nov 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 13 Aug 2024 | Piper Sandler | Overweight | Overweight | maintain |
| 13 Aug 2024 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 13 Aug 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 1 Aug 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 26 Jun 2024 | HC Wainwright & Co. | Buy | Buy | maintain |